Selumetinib in Treating Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma
Clinical trial NCT01278615 · TERMINATED
Trial details
- NCT number
- NCT01278615
- Sponsor
- National Cancer Institute (NCI)
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-12-01
- Primary completion
- 2014-02-01
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.